Immunotherapy Approved for Advanced Bladder Cancer (FREE)

By Kristin J. Kelley Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS The FDA has approved the immunotherapy atezolizumab (marketed as Tecentriq) to treat metastatic or locally advanced urothelial …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news